Hemispherx Biopharma changes name to AIM ImmunoTech
Hemispherx Biopharma announced it has changed its name to AIM ImmunoTech effective September 3, 2019. Additionally, the Company announced the Company's ticker will change to "AIM." The Company's common stock will continue to trade on the NYSE American. August 23, 2019